Display options
Share it on

Neurol Genet. 2019 Apr 23;5(3):e335. doi: 10.1212/NXG.0000000000000335. eCollection 2019 Jun.

Oligogenic basis of sporadic ALS: The example of .

Neurology. Genetics

Liina Kuuluvainen, Karri Kaivola, Saana Mönkäre, Hannu Laaksovirta, Manu Jokela, Bjarne Udd, Miko Valori, Petra Pasanen, Anders Paetau, Bryan J Traynor, David J Stone, Johanna Schleutker, Minna Pöyhönen, Pentti J Tienari, Liisa Myllykangas

Affiliations

  1. Department of Clinical Genetics (L.K.), Helsinki University Hospital; Department of Medical Genetics (L.K.), University of Helsinki, Helsinki, Finland; Molecular Neurology (K.K., M.V., P.J.T.), Research Programs Unit, Biomedicum, University of Helsinki, Helsinki, Finland; Department of Medical Genetics (S.M.), University of Helsinki, Helsinki, Finland and Turku; University Hospital (S.M.), Laboratory Division, Genetics and Saske, Department of Medical Genetics, Turku, Finland; Department of Neurology (H.L.), Helsinki University Hospital, and Molecular Neurology, Research Programs Unit, Biomedicum, University of Helsinki, Helsinki, Finland; Neuromuscular Research Center (M.J., B.U.), Tampere University Hospital and University of Tampere, Tampere, Finland; Division of Clinical Neurosciences (M.J.), Turku University Hospital and University of Turku, Turku, Finland; Folkhälsan Research Center (B.U.), Biomedicum, University of Helsinki, Helsinki, Finland; Institute of Biomedicine (P.P., J.S.), University of Turku; Turku University Hospital (P.P., J.S.), Laboratory Division, Genetics and Saske, Department of Medical Genetics, Turku, Finland; Department of Pathology (A.P.), University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Laboratory of Neurogenetics (B.J.T.), National Institute on Aging, National Institutes of Health, Bethesda, MD; Merck & Co. (D.J.S.), Inc., West Point, PA; Department of Clinical Genetics (M.P.), Helsinki University Hospital; Department of Medical Genetics (M.P.), University of Helsinki, Helsinki, Finland; Department of Neurology (P.J.T.), Helsinki University Hospital; and Department of Pathology (L.M.), University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

PMID: 31086828 PMCID: PMC6481226 DOI: 10.1212/NXG.0000000000000335

Abstract

OBJECTIVE: To characterize the clinical and neuropathologic features of patients with amyotrophic lateral sclerosis (ALS) with the superoxide dismutase 1 (

METHODS: An index patient with autopsy-proven ALS was discovered to have the

RESULTS: Seven screened patients (1.5%) were found to carry the

CONCLUSIONS: Our data suggest that the penetrance of

References

  1. Brain. 2001 Jul;124(Pt 7):1461-6 - PubMed
  2. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):162-6 - PubMed
  3. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Jun;4(2):62-73 - PubMed
  4. Ann Neurol. 2007 May;61(5):427-34 - PubMed
  5. Neuron. 2011 Oct 20;72(2):257-68 - PubMed
  6. Ann Neurol. 2012 Nov;72(5):739-49 - PubMed
  7. Brain Res. 2015 May 14;1607:75-93 - PubMed
  8. Ann Neurol. 2015 Jan;77(1):100-13 - PubMed
  9. Nature. 2016 Aug 17;536(7616):285-91 - PubMed
  10. J Neuropathol Exp Neurol. 1998 Oct;57(10):895-904 - PubMed

Publication Types